Clicky

Novartis AG(NVS)

Description: Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.


Keywords: Biotechnology Pharmaceutical Drugs Medication Pharmacy Infectious Diseases Antibiotics Active Pharmaceutical Ingredients Healthcare Products Ophthalmology Neuroscience Eye Disposable Products Eyewear Molecular Diagnostics Lenses Ophthalmic Primary Care Disposable Product Metabolism Prescription Drugs Blood Test Over The Counter Drug Animal Health Contact Lens Contact Lenses Diagnostics Products Intraocular Lens Surgical Equipment Eye Care Products Eye Care Veterinary Products Biotechnology Based Products Lens Care Products Molecular Diagnostics Products

Home Page: www.novartis.com

NVS Technical Analysis

Lichtstrasse 35
Basel, 4056
Switzerland
Phone: 41 61 324 1111


Officers

Name Title
Dr. Vasant Narasimhan Chief Exec. Officer
Mr. Harry Kirsch Chief Financial Officer
Dr. Klaus Moosmayer Ph.D. Chief Ethics, Risk & Compliance Officer
Ms. Karen L. Hale Chief Legal Officer
Dr. Robert Kowalski Pharm.D. Chief People & Organization Officer
Mr. Steffen Lang Ph.D. Pres of Operations
Ms. Marie-France Tschudin Pres of Innovative Medicines International & Chief Commercial Officer
Mr. Richard Saynor Chief Exec. Officer of Sandoz
Paul Penepent Head of Group Financial Reporting and Accounting
Dr. Samir Shah M.D. Global Head of Investor Relations

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 14.5349
Trailing PE: 9.3263
Price-to-Book MRQ: 3.2725
Price-to-Sales TTM: 3.7233
IPO Date: 1991-11-18
Fiscal Year End: December
Full Time Employees: 108000
Back to stocks